Engineering chimeric antigen receptor CD4 T cells for Alzheimer’s disease

30

Engineering chimeric antigen receptor CD4 T cells for Alzheimer’s disease

Tags:

Previous Article

E. coli and 'good' bacteria balanced by breastmilk in baby gut microbiomes

Engineered immune cells reduce plaques in Alzheimer’s disease

Related Posts

Triglyceride metabolism controls inflammation and microglial phenotypes associated with APOE4

Triglyceride metabolism controls inflammation and micro...

209

Maternal diabetes programs sexually dimorphic early-onset cardiovascular dysfunction in metabolically healthy offspring

Maternal diabetes programs sexually dimorphic early-ons...

53

How macrophage heterogeneity affects tuberculosis disease and therapy

How macrophage heterogeneity affects tuberculosis disea...

99